These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34597335)

  • 1. Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
    Tezuka Y; Eguchi-Ishimae M; Ozaki E; Ito T; Ishii E; Eguchi M
    PLoS One; 2021; 16(10):e0258090. PubMed ID: 34597335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
    Sasaki Y; Shimizu Y; Suzuki Y; Horikoshi S; Tomino Y
    BMC Nephrol; 2015 Mar; 16():27. PubMed ID: 25885587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14.
    Guo Y; Liao Y
    Int Immunopharmacol; 2017 Nov; 52():150-155. PubMed ID: 28910745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible immediate early response protein 14 in oral squamous cell carcinoma and its implications.
    Acharya S; Prabhu P; Patil VS; Acharya AB; Nikhil K
    J Investig Clin Dent; 2019 Nov; 10(4):e12469. PubMed ID: 31541512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells in renal biology: bone marrow transplantation for the treatment of IgA nephropathy.
    Imasawa T; Utsunomiya Y
    Exp Nephrol; 2002; 10(1):51-8. PubMed ID: 11803205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy.
    Tokunaga K; Uto H; Takami Y; Mera K; Nishida C; Yoshimine Y; Fukumoto M; Oku M; Sogabe A; Nosaki T; Moriuchi A; Oketani M; Ido A; Tsubouchi H
    Biochem Biophys Res Commun; 2010 Aug; 399(2):144-9. PubMed ID: 20637724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal mapping of hyperserum IgA and glomerular IgA deposition in a high IgA (HIGA) strain of DdY mice.
    Nogaki F; Oida E; Kamata T; Kobayashi I; Nomura K; Suyama K; Tahara S; Ono T; Miyawaki S; Serikawa T; Yoshida H; Kita T; Muso E
    Kidney Int; 2005 Dec; 68(6):2517-25. PubMed ID: 16316328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.
    Xia Y; Herlitz LC; Gindea S; Wen J; Pawar RD; Misharin A; Perlman H; Wu L; Wu P; Michaelson JS; Burkly LC; Putterman C
    J Am Soc Nephrol; 2015 May; 26(5):1053-70. PubMed ID: 25270074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy.
    Wu D; Li X; Yao X; Zhang N; Lei L; Zhang H; Tang M; Ni J; Ling C; Chen Z; Chen X; Liu X
    Clin Exp Nephrol; 2021 Jun; 25(6):641-651. PubMed ID: 33620604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
    Hashimoto A; Suzuki Y; Suzuki H; Ohsawa I; Brown R; Hall S; Tanaka Y; Novak J; Ohi H; Tomino Y
    Am J Pathol; 2012 Oct; 181(4):1338-47. PubMed ID: 22871574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular angiotensin-converting enzyme 2 in pediatric IgA nephropathy.
    Urushihara M; Seki Y; Tayama T; Nagai T; Kinoshita Y; Jamba A; Kondo S; Kagami S
    Am J Nephrol; 2013; 38(5):355-67. PubMed ID: 24158104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF.
    He L; Peng X; Chen Y; Liu G; Liu Z; Zhu J; Liu Y; Liu H; Liang Y; Liu F; Sun L; Peng Y
    Am J Nephrol; 2016; 43(3):179-94. PubMed ID: 27073891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice.
    Miyakawa R; Sato A; Matsuda Y; Saito A; Abe F; Matsumura H; Odaka M; Suzuki T; Dohmae N; Komatsuda A; Takahashi N; Wakui H
    Clin Exp Nephrol; 2020 Aug; 24(8):666-679. PubMed ID: 32436031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathogenic role for secretory IgA in IgA nephropathy.
    Oortwijn BD; van der Boog PJ; Roos A; van der Geest RN; de Fijter JW; Daha MR; van Kooten C
    Kidney Int; 2006 Apr; 69(7):1131-8. PubMed ID: 16395264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children.
    Mao S; Xuan X; Sha Y; Zhao S; Zhu C; Zhang A; Huang S
    Int J Clin Exp Pathol; 2015; 8(3):2334-42. PubMed ID: 26045740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy.
    Takahata A; Arai S; Hiramoto E; Kitada K; Kato R; Makita Y; Suzuki H; Nakata J; Araki K; Miyazaki T; Suzuki Y
    J Am Soc Nephrol; 2020 Sep; 31(9):2013-2024. PubMed ID: 32611589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
    Tian J; Wang Y; Guo H; Li R
    Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.